Lybocent
ActiveSummary
The computed 12-month bankruptcy probability of Lybocent is 4.4% (elevated). The 2025 annual accounts show equity of €18,802 and a net result of €8,259. Its solvency ranks better than 40% of 21,983 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-08
Gazette deed
Registered office · Purpose · Amendment of the articlesDeclaration · Registered-office move · Power of attorney7 facts ▸
Gazette deed
Registered office · Purpose · Amendment of the articles
Declaration · Registered-office move · Power of attorney7 facts ▸
- Declaration, “verslag van het bestuursorgaan betreffende de wijziging van het voorwerp, ontslag van voorlezing” (deed in Dutch)
- General meeting, 25-08-2026
- Declaration, “verslag van het bestuursorgaan, kennisname” (deed in Dutch)
- Registered-office move, 9050 Gent (Ledeberg), Hundelgemsesteenweg 27
- Power of attorney, CRVB Accountancy
- Power of attorney, Ann Crommelinck
- Board meeting, “gemachtigd tot uitvoering van de voormelde besluiten, bestuursorgaan” (deed in Dutch)
30-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-01
NBB filing
Annual accounts filed
financial year 2024 · micro format
Gazette deedNBB filing
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.